diucifon has been researched along with Sclerosis, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedorova, EG; Grebeniuk, VN; Sheklakova, MN | 1 |
| Abdrakhmanova, RSh; Bilich, IL; Bombina, LK; Khalfieva, GM; Mangusheva, MM | 1 |
2 trial(s) available for diucifon and Sclerosis, Systemic
| Article | Year |
|---|---|
[Diucifon in the therapy of dermatoses].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Dermatitis Herpetiformis; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Scleroderma, Systemic; Skin Diseases; Sulfones; Time Factors; Uracil | 1980 |
[Evaluation of the effectiveness of diucifon in rheumatoid arthritis and systemic scleroderma].
Topics: Adult; Anti-Inflammatory Agents; Antigen-Antibody Complex; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Combinations; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Scleroderma, Systemic; Sulfones; Uracil | 1986 |